SHG Provides Compensation Analysis to GB Sciences, Inc.
SHG is pleased to announce it has completed a detailed compensation analysis for GB Sciences, Inc., for the benefit of attracting and retaining the senior leadership team. Our analysis was used among management and its advisors.
About GB Sciences, Inc.
GB Sciences is a biopharmaceutical and cannabinoid-based drug development company whose goal is to create patented formulations for safe, standardized, cannabinoid therapies that target a variety of medical conditions in both the pharmaceutical and wellness markets. To learn more about GB Sciences please visit Home - GB Sciences.
Navigate market uncertainty with compensation studies. Learn how to attract talent, retain employees, and make smart budget decisions. Download our free guide.
Discover Edward Heslop, a visionary entrepreneur and sustainability strategist with over 30 years of experience transforming research into impactful solutions.
